|
tweede vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met recombinant-eiwitvaccin van 'spike'-antigeen (verrichting)
tweede vaccinatie tegen SARS-CoV-2 met recombinant-S-eiwitvaccin
tweede actieve immunisatie met recombinant-'spike'-eiwit van SARS-CoV-2
tweede toediening van vaccin met recombinant-S-eiwit tegen COVID-19
tweede vaccinatie tegen 'Severe acute respiratory syndrome'-coronavirus 2 met recombinant-eiwitvaccin van 'spike'-antigeen
Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine
Second dose of 2019-nCoV recombinant spike protein antigen vaccination
Second dose of COVID-19 recombinant spike protein antigen immunization
Second dose of COVID-19 recombinant spike protein antigen vaccination
Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen
Second dose of 2019-nCoV recombinant spike protein antigen immunization
Second dose of SARS-CoV-2 recombinant spike protein antigen immunization
Second dose of SARS-CoV-2 recombinant spike protein antigen vaccination
Second dose of 2019 novel coronavirus recombinant spike protein antigen immunization
Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccination
Second dose of 2019 novel coronavirus recombinant spike protein antigen vaccination
Id1162646009
StatusPrimitive
Global Patient Set